Interaction of Genetic and Environmental Factors for Body Fat Mass Control
NCT ID: NCT04299698
Last Updated: 2020-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
259 participants
OBSERVATIONAL
2017-06-07
2018-02-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Health Lifestyle on Body Weight
NCT05608226
Investigation of Genetic Marker Associated With Obesity in Koreans
NCT01341860
Gene-diet Interactions on Body Weight Regulation and Lifestyle Parameters.
NCT04699448
Effect of Weight Reduction on Inflammatory Markers and Genes Expression in Obese Individuals
NCT00416156
GWAS in a Small Group of Metabolically Healthy Obese White Adults
NCT02105909
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Carbohydrate reduction group
Participants chose to control their body fat mass by reducing their carbohydrate intake through observation study periods.
lifestyle
Participants who desire to control body fat mass chose the one of lifestyle modification on their diet or exercise.
Fat reduction group
Participants chose to control their body fat mass by reducing their fat intake through observation study periods.
lifestyle
Participants who desire to control body fat mass chose the one of lifestyle modification on their diet or exercise.
Intense exercise group
Participants chose to control their body fat mass by vigorously increasing the time and intensity of exercise through observation study periods.
lifestyle
Participants who desire to control body fat mass chose the one of lifestyle modification on their diet or exercise.
Moderate exercise group
Participants chose to control their body fat mass by moderately increasing the time and intensity of exercise through observation study periods.
lifestyle
Participants who desire to control body fat mass chose the one of lifestyle modification on their diet or exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lifestyle
Participants who desire to control body fat mass chose the one of lifestyle modification on their diet or exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant women
* Participants taking weight control pills
19 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Semiconductor R&D center
UNKNOWN
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Woong-Yang Park
Head of Samsung Genomic institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Woong-Yang Park, MD
Role: STUDY_CHAIR
Samsung Genomic Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-03-064
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.